We found that in breast cancer patients, EZH2 expression scores correlated significantly with Ki-67 expression scores in both primary and metastatic lesions and Ki-67 expression and EZH2 expression scores were significantly higher in metastatic lesions compared with PBC lesions. This evidence concerns the gene MKI67 and primary biliary cholangitis.